Dimiracetam

DB13018InvestigationalSmall molecule

Dimiracetam has been used in trials studying the treatment of AIDS, Neuropathy, and Acquired Immunodeficiency Syndrome.

Chemical structure of Dimiracetam
Formula / weight
C6H8N2O2 · 140.142 g/mol (avg)

Resolves to

Compound
UNII4AW7F70MZOCAS126100-97-8ChEMBLCHEMBL337612PubChem65955
Structure
InChIKeyXTXXOHPHLNROBN-UHFFFAOYSA-NSMILESO=C1CN2C(CCC2=O)N1

What you can answer from here — as of February 21, 2021

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Dimiracetam, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In